LifeFlow Sepsis Study
Withdrawn before enrolling · Not applicable
Conditions studied: Sepsis
In brief
This is a prospective, comparative, blinded, randomized study to prove the safety, efficacy and ease of use of the LifeFlow® device in pediatric patients presenting to an emergency department with concern for sepsis. This study will include 600 patients, 300 will receive the LifeFlow® device to deliver intravenous fluids while another 300 patients will receive the conventional push/pull method.
Key facts
- Study ID
- NCT07191054
- Run by
- Phoenix Children's Hospital
- People needed
- 0
- Starts
- 2019-05-01
- Expected to finish
- 2020-03-30
- Last updated by the study team
- 2025-09-24
Who can join
Age: 1 and older, up to 19. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Less than 19 years old
- Trigger the Best Practice Alert in triage
- Treating physician elects to do the full sepsis bundle.
You may not qualify if…
- Less than 20kg in weight
- Patients on diuretics for cardiac or renal conditions
- Patients who cannot communicate in either English or Spanish
Where it is running
- Phoenix Children's — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.